Discovery of amide-functionalized benzimidazolium salts as potent α-glucosidase inhibitors
α-Glucosidase inhibitors (AGIs) are used as medicines for the treatment of diabetes mellitus. The α-Glucosidase enzyme is present in the small intestine and is responsible for the breakdown of carbohydrates into sugars. The process results in an increase in blood sugar levels. AGIs slow down the dig...
Published in: | Molecules |
---|---|
Main Author: | 2-s2.0-85112329694 |
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112329694&doi=10.3390%2fmolecules26164760&partnerID=40&md5=bc2b6a585ad05ed6048fce3d82640811 |
Similar Items
-
Development of benzimidazolium salt-based cubosome hydrogel for topical treatment of burns
by: 2-s2.0-85217012735
Published: (2025) -
Synthesis of Indole Based Sulfonamide Derivatives as potent inhibitors of α-glucosidase and α-amylase in management of type-II diabetes
by: 2-s2.0-85185155619
Published: (2024) -
Novel quinoline derivatives as potent in vitro α-glucosidase inhibitors: In silico studies and SAR predictions
by: 2-s2.0-84943771420
Published: (2015) -
Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions
by: 2-s2.0-84942794211
Published: (2015) -
Synthesis and biological evaluation of novel coumarin derivatives bearing sulfonamide moiety as potent α-glucosidase inhibitors
by: Alsukor A.; Inayatsyah N.A.; Ridhwan M.J.M.; Kasim N.; Imran S.
Published: (2025)